• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Allergan Aesthetics is a hot mess





Or the mouth breather whispering preclinical device guy they parade as an RnD head will fix it. Look what the visionary has done so far. Hot mess does not begin to describe it.
Something tells me the good ole days may be gone for good. The market has changed and become much more competitive fighting while for the less valuable dollar. Double digit growth in FA will be very challenging sadly! Just my 2 cents from 20 years here.
 




Something tells me the good ole days may be gone for good. The market has changed and become much more competitive fighting while for the less valuable dollar. Double digit growth in FA will be very challenging sadly! Just my 2 cents from 20 years here.
A ton of products to choose from now with many companies massively discounting trying to gain ground.
 




Something tells me the good ole days may be gone for good. The market has changed and become much more competitive fighting while for the less valuable dollar. Double digit growth in FA will be very challenging sadly! Just my 2 cents from 20 years here.
Thoughts on LRM Aesthetic? Looks like a ton of Allergan people there. Is the product any good? Would love feedback.
 








Is Evolus having much of an impact on Botox or just unreachable growth expectations?
Evolution had traction in the beginning but they blew the launch. Overpromised outcomes, high price point, lack of 6 month efficacy, people tried it and then majority never reordered. Lasted 3-4 months, burned when injected and was way too expensive.
 












Is Evolus having much of an impact on Botox or just unreachable growth expectations?
Evolus is just the distributor of a 2nd class Korean toxin. They are growing but the product is not great. Soon Evolus will start distributing a toxin but they are entering the game very late. Not a real threat to Allergan.
 




Is it just me or is this place getting worse? Old products, lots of competition and incompetent R&D. I mean leadership can have another offsite and the subsequent LinkedIn posts but is there any hope things improve? This used to be THE place.
 




Is it just me or is this place getting worse? Old products, lots of competition and incompetent R&D. I mean leadership can have another offsite and the subsequent LinkedIn posts but is there any hope things improve? This used to be THE place.
Allergan used to be the reference in aesthetics, but no longer. Old products, high prices, lack of innovation, share loss due to competitive pressure, low category growth…
It’s just the beginning of the downward spiral.